Browsing by Yonsei Author : Park, Jun Yong

Name:
Park, Jun Yong [박준용] http://orcid.org/0000-0001-6324-2224
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
(47861376300)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 349

This table browses all dspace content
Issue DateTitleJournal Title
2021Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial PeritonitisCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients JOURNAL OF KOREAN MEDICAL SCIENCE
2021Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2021Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis BHEPATOLOGY RESEARCH
2021Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular CarcinomaCANCER INVESTIGATION
2021Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization CURRENT ONCOLOGY
2021Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2021Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy GUT AND LIVER
2021Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2021Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovirJOURNAL OF VIRAL HEPATITIS
2021Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 yearsJOURNAL OF DIABETES AND ITS COMPLICATIONS
2020A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapyJOURNAL OF VIRAL HEPATITIS
2020Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus InfectionCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020Genetic risk factors associated with NAFLDHepatoma Research
2020Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion JOURNAL OF HEPATOCELLULAR CARCINOMA
2020Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemiaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020Tenofovir-based combination therapy or monotherapy for multidrug-resistant chronic hepatitis B: Long-term data from a multicenter cohort studyJOURNAL OF VIRAL HEPATITIS
2020Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2020The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization GUT AND LIVER
2020Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals CANCERS
2020Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis BDIGESTIVE AND LIVER DISEASE
2020High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosisJOURNAL OF VIRAL HEPATITIS
2020Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop CLINICAL AND MOLECULAR HEPATOLOGY
2020Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic AttackCEREBROVASCULAR DISEASES
2020Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry Journal of Liver Cancer (대한간암학회지)
2020Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus GUT AND LIVER
2020Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinomaJOURNAL OF VIRAL HEPATITIS
2020Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation CANCERS
2020Human liver CD8 + MAIT cells exert TCR/MR1-independent innate-like cytotoxicity in response to IL-15JOURNAL OF HEPATOLOGY
2020Renal safety of tenofovir disoproxil fumarate and entecavir with hepatitis B immunoglobulin in liver transplant patientsJOURNAL OF VIRAL HEPATITIS
2020Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab inductionAMERICAN JOURNAL OF TRANSPLANTATION
2020An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremiaLIVER INTERNATIONAL
2020Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal responseCLINICAL AND MOLECULAR HEPATOLOGY
2020Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phaseALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study GUT AND LIVER
2020Functions of human liver CD69 + CD103 - CD8 + T cells depend on HIF-2α activity in healthy and pathologic liversJOURNAL OF HEPATOLOGY
2020Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial RadioembolizationEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionLIVER INTERNATIONAL
2020경구 항바이러스제 치료로 완치받은 C형간염 환자에서 간세포암종 발생의 장기 위험 Korean Journal of Gastroenterology
2020Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B JOURNAL OF KOREAN MEDICAL SCIENCE
2020Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskAMERICAN JOURNAL OF GASTROENTEROLOGY
2020Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinomaHEPATOLOGY INTERNATIONAL
2020Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry Journal of Liver Cancer (대한간암학회지)
2020Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure Journal of Liver Cancer (대한간암학회지)
2020Design and Validation of Risk Prediction Model for Hepatocellular Carcinoma Development After Sustained Virological Response in Patients With Chronic Hepatitis CEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020HKR3 Regulates Cell Cycle Through the Inhibition of hTERT in Hepatocellular Carcinoma Cell Lines JOURNAL OF CANCER
2020Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest? IMMUNE NETWORK
2020A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea CLINICAL AND MOLECULAR HEPATOLOGY
2020Hepatocellular Carcinoma Risk Steadily Persists Over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter StudyCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Browse

Links